FDA MedWatch

Levemir Insulin (Novo Nordisk)

Audience : Patients, pharmacists, diabetes healthcare professionals

06/13/2009 - FDA notified patients and healthcare professionals that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. are being sold in the U.S. market, may not have been stored and handled properly, and may be dangerous for patients to use. The agency is advising patients who use Levemir insulin to:

• Check your personal supply of insulin to determine if you have Levemir insulin from one of the following lots: XZF0036, XZF0037, and XZF0038. 
• Do not use your Levemir insulin if it is from one of these lots.
• Always visually inspect your insulin before using it. Levemir is a clear and colorless solution.
• Contact the Novo Nordisk Customer Care Center at 1-800-727-6500 for what to do with vials from these lots or if you have any other questions.

Read the complete MedWatch 2009 Safety Summary, including a link to the FDA News Release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsfo
rHumanMedicalProducts/ucm166359.html